Skip to Content
Merck

Bioengineered human tumor within a bone niche.

Biomaterials (2014-04-22)
Aranzazu Villasante, Alessandro Marturano-Kruik, Gordana Vunjak-Novakovic
ABSTRACT

Monolayer cultures of tumor cells and animal studies have tremendously advanced our understanding of cancer biology. However, we often lack animal models for human tumors, and cultured lines of human cells quickly lose their cancer signatures. In recent years, simple 3D models for cancer research have emerged, including cell culture in spheroids and on biomaterial scaffolds. Here we describe a bioengineered model of human Ewing's sarcoma that mimics the native bone tumor niche with high biological fidelity. In this model, cancer cells that have lost their transcriptional profiles after monolayer culture re-express genes related to focal adhesion and cancer pathways. The bioengineered model recovers the original hypoxic and glycolytic tumor phenotype, and enables re-expression of angiogenic and vasculogenic mimicry features that favor tumor adaptation. We propose that differentially expressed genes between the monolayer cell culture and native tumor environment are potential therapeutic targets that can be explored using the bioengineered tumor model.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Periodic acid, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Hematoxylin, certified by the Biological Stain Commission
Sigma-Aldrich
Hematoxylin
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Periodic acid, 99.999% trace metals basis
Sigma-Aldrich
Periodic acid, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Periodic acid, puriss. p.a., ACS reagent, for oxidimetric titration, crystallized, ≥99.0% (RT)
Sigma-Aldrich
Periodic acid, ACS reagent, 99%
Sigma-Aldrich
Pimonidazole, ≥98% (HPLC)